These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 15505064)

  • 41. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wide-field fundus autofluorescence imaging of retinitis pigmentosa.
    Oishi A; Ogino K; Makiyama Y; Nakagawa S; Kurimoto M; Yoshimura N
    Ophthalmology; 2013 Sep; 120(9):1827-34. PubMed ID: 23631947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes.
    Messias K; Jägle H; Saran R; Ruppert AD; Siqueira R; Jorge R; Messias A
    Doc Ophthalmol; 2013 Oct; 127(2):123-9. PubMed ID: 23733195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration.
    Schmitz-Valckenberg S; Bültmann S; Dreyhaupt J; Bindewald A; Holz FG; Rohrschneider K
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4470-6. PubMed ID: 15557456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photopic electroretinogram implicit time in retinitis pigmentosa.
    Iijima H; Yamaguchi S; Hosaka O
    Jpn J Ophthalmol; 1993; 37(2):130-5. PubMed ID: 8230836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rhodopsin and visual threshold in retinitis pigmentosa.
    Ripps H; Brin KP; Weale RA
    Invest Ophthalmol Vis Sci; 1978 Aug; 17(8):735-45. PubMed ID: 681133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multifocal ERG reveals several patterns of cone degeneration in retinitis pigmentosa with concentric narrowing of the visual field.
    Janáky M; Pálffy A; Deák A; Szilágyi M; Benedek G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):383-9. PubMed ID: 17197558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypotrichosis with juvenile macular dystrophy: clinical and electrophysiological assessment of visual function.
    Leibu R; Jermans A; Hatim G; Miller B; Sprecher E; Perlman I
    Ophthalmology; 2006 May; 113(5):841-7.e3. PubMed ID: 16650681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Seeing in the dusk: physiological basis and investigation].
    Friedburg C
    Klin Monbl Augenheilkd; 2004 Jul; 221(7):570-6. PubMed ID: 15273912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Symptomatic abnormalities of dark adaptation in patients with EFEMP1 retinal dystrophy (Malattia Leventinese/Doyne honeycomb retinal dystrophy).
    Haimovici R; Wroblewski J; Piguet B; Fitzke FW; Holder GE; Arden GB; Bird AC
    Eye (Lond); 2002 Jan; 16(1):7-15. PubMed ID: 11913893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association between visual acuity and central retinal thickness in retinitis pigmentosa.
    Sandberg MA; Brockhurst RJ; Gaudio AR; Berson EL
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3349-54. PubMed ID: 16123439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinal functions in snowflake degeneration.
    Hirose T; Wolf E; Schepens CL
    Ann Ophthalmol; 1980 Oct; 12(10):1135-46. PubMed ID: 7283319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implicit time topography of multifocal electroretinograms.
    Seeliger MW; Kretschmann UH; Apfelstedt-Sylla E; Zrenner E
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):718-23. PubMed ID: 9538878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between visual sensitivity and rhodopsin density in retinitis pigmentosa.
    Perlman I; Auerbach E
    Invest Ophthalmol Vis Sci; 1981 Jun; 20(6):758-65. PubMed ID: 7239846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychophysical evidence for rod vulnerability in age-related macular degeneration.
    Owsley C; Jackson GR; Cideciyan AV; Huang Y; Fine SL; Ho AC; Maguire MG; Lolley V; Jacobson SG
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):267-73. PubMed ID: 10634630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphenes electrically evoked with DTL electrodes: a study in patients with retinitis pigmentosa, glaucoma, and homonymous visual field loss and normal subjects.
    Gekeler F; Messias A; Ottinger M; Bartz-Schmidt KU; Zrenner E
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4966-74. PubMed ID: 17065515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The coexistence of age-related macular degeneration and retinitis pigmentosa in three unrelated families.
    Sarraf D; Salib DM; Jain A; Quiram PA
    Semin Ophthalmol; 2007; 22(3):155-61. PubMed ID: 17763236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormal foveal spectral sensitivity in retinitis pigmentosa.
    Alexander KR; Hutman LP; Fishman GA
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):725-30. PubMed ID: 3557876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.